Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019–2024

Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019–2024

Patient-centric and Safety-focused Logistical Solutions will Create New Growth Opportunities

RELEASE DATE
21-Aug-2020
REGION
Global
Research Code: PB21-01-00-00-00
SKU: HC03327-GL-MT_24662
$4,950.00
In stock
SKU
HC03327-GL-MT_24662
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

In this research deliverable, Frost & Sullivan’s analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new trials. This research service will help participants plan their production pipeline and be well prepared to tackle the dynamic market situation and the post-COVID-19 impact. This short report covers the Global Contract Research Organization Market (CRO) insights, with forecast for the total CRO market, including drug discovery and preclinical markets, with 2019 as the base year and 2020–2024 as the forecast period. Market revenue is measured in US dollars. It presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides global, post-pandemic revenue forecasts for CROs. Further, qualitative information will be provided on support services, such as central laboratory services, bioanalytics, and data management. The report identifies strong CRO opportunities, with the evolving digitized ecosystem of the clinical trials due to COVID-19. The two key market trends identified are increased adoption of hybrid clinical trials and remote patient monitoring.


Research Highlights

  • Pre-/post-COVID-19 impact and growth trajectory of the CRO market
  • Future market outlook and underlying trends
  • Major growth opportunities

Author: Khushbu Jain 

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Revised State of the CRO Market Due to the Pandemic

Key Forecast Criteria

Scope and Segmentation

Total Market Revenue Forecast

Total Market Revenue Forecast—Original and Revised Forecast Comparison

Drug Discovery and Preclinical CRO Revenue Forecast

Drug Discovery and Preclinical CRO Market—Post-COVID-19 Revenue Scenario

Clinical Segment Revenue Forecast

Distribution of Disrupted Trial Sites

COVID-19 Trials by Regions and Phases

Disrupted Trials—Discussion

Revenue Forecast by Peripheral Segments

Other Forecast Trends

Policy and Regulations

Policy and Regulations (continued)

Policy and Regulations (continued)

Global CRO Market Future Outlook

Global CRO Market Future Outlook (Continued)

Growth Opportunity 1: Clinical Trials for Digital Therapeutics, 2019

Growth Opportunity 1: Clinical Trials for Digital Therapeutics, 2019 (continued)

Growth Opportunity 2: Clinical Trial IT Solutions for RPM and Telemedicine, 2019

Growth Opportunity 2: Clinical Trial IT Solutions for RPM and Telemedicine, 2019 (continued)

Growth Opportunity 3: Logistical Solutions for Direct-to-Consumer Approach, 2019

Growth Opportunity 3: Logistical Solutions for Direct-to-Consumer Approach, 2019 (continued)

About the Growth Pipeline Engine™

Next Steps

List of Exhibits

Legal Disclaimer

Related Research
In this research deliverable, Frost & Sullivan’s analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new trials. This research service will help participants plan their production pipeline and be well prepared to tackle the dynamic market situation and the post-COVID-19 impact. This short report covers the Global Contract Research Organization Market (CRO) insights, with forecast for the total CRO market, including drug discovery and preclinical markets, with 2019 as the base year and 2020–2024 as the forecast period. Market revenue is measured in US dollars. It presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides global, post-pandemic revenue forecasts for CROs. Further, qualitative information will be provided on support services, such as central laboratory services, bioanalytics, and data management. The report identifies strong CRO opportunities, with the evolving digitized ecosystem of the clinical trials due to COVID-19. The two key market trends identified are increased adoption of hybrid clinical trials and remote patient monitoring.--BEGIN PROMO--

Research Highlights

  • Pre-/post-COVID-19 impact and growth trajectory of the CRO market
  • Future market outlook and underlying trends
  • Major growth opportunities

Author: Khushbu Jain 

More Information
No Index No
Podcast No
Author Khushbu Jain
Industries Healthcare
WIP Number PB21-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9611-B1